Ultragenyx Pharmaceutical Inc. buy Guggenheim
Start price
05.01.26
/
50%
€20.00
Target price
05.01.27
€44.47
Performance (%)
14.95%
Price
13.08.26
€22.77
Summary
This prediction is currently active. The BUY prediction by Guggenheim currently has a performance of 14.95%. This prediction currently runs until 05.01.27. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | -1.869% | -1.869% |
| iShares Core DAX® | 0.881% | 5.632% |
| iShares Nasdaq 100 | 2.390% | 1.571% |
| iShares Nikkei 225® | 4.269% | 2.521% |
| iShares S&P 500 | 1.171% | 2.545% |
Comments by Guggenheim for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Guggenheim from $64.00 to $52.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat
Stopped prediction by Guggenheim for Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.39
04.08.26
04.08.26
€30.41
04.08.27
04.08.27
2.68%
13.08.26
13.08.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€22.10
08.05.26
08.05.26
€36.67
08.05.27
08.05.27
2.40%
13.08.26
13.08.26
Ultragenyx Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€32.00
20.06.25
20.06.25
€55.59
20.06.26
20.06.26
-26.03%
21.06.26
21.06.26